Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

• Publication date: January 2013
• Report size: 167 pages

Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five market c...

Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018



Summary



GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Infectious Immunology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within five market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.



Scope


- Market size data for Infectious Immunology market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology
- Annualized market revenues ($m) data for each of the segments and sub-segments within the five market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Infectious Immunology market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Infectious Immunology market in BRICS.
- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Shanghai Kehua Bio-engineering Co., Ltd., Siemens Healthcare, bioMerieux S.A., DiaSorin S.p.A, Qiagen N.V., Transasia Bio-Medicals Ltd., Alere Inc., Beckman Coulter, Inc., Gen-Probe Incorporated, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Trivitron Healthcare Pvt Ltd., Span Diagnostics Ltd., Thermo Fisher Scientific Inc., Tulip Diagnostics (P) Ltd, Cellestis Limited, Chembio Diagnostics, Inc. and Hologic, Inc.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Infectious Immunology competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

General Medicine And Specialty Medicine Industry in China

Table of Contents

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What is This Report About? 14
3 Infectious Immunology in BRICS 15
3.1 Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
3.2 Infectious Immunology, BRICS, Company share (2010-2011) 21
4 Infectious Immunology In Brazil 23
4.1 Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
4.2 Hepatitis Viruses In Brazi 29
4.2.1 Hepatitis Viruses, Brazil, Overall Revenue (2004-2018) 29
4.3 Other Virology In Brazil 31
4.3.1 Other Virology, Brazil, Overall Revenue (2004-2018) 31
4.4 Retroviruses In Brazil 33
4.4.1 Retroviruses, Brazil, Overall Revenue (2004-2018) 33
4.5 Bacteriology In Brazil 35
4.5.1 Bacteriology, Brazil, Overall Revenue (2004-2018) 35
4.6 Infectious Immunology Rapid Tests In Brazil 37
4.6.1 Infectious Immunology Rapid Tests, Brazil, Overall Revenue (2004-2018) 37
4.7 Infectious Immunology, Brazil, Distribution Share (2010-2011) 41
4.8 Infectious Immunology, Brazil, Company Share (2010-2011) 42
5 Infectious Immunology In Russian Federation 44
5.1 Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 44
5.2 Hepatitis Viruses In Russian Federation 50
5.2.1 Hepatitis Viruses, Russian Federation, Overall Revenue (2004-2018) 50
5.3 Retroviruses In Russian Federation 52
5.2.2 Retroviruses, Russian Federation, Overall Revenue (2004-2018) 52
5.3 Other Virology In Russian Federation 54
5.3.1 Other Virology, Russian Federation, Overall Revenue (2004-2018) 54
5.4 Bacteriology In Russian zFederation 56
5.4.1 Bacteriology, Russian Federation, Overall Revenue (2004-2018) 56
5.5 Infectious Immunology Rapid Tests In Russian Federation 58
5.5.1 Infectious Immunology Rapid Tests, Russian Federation, Overall Revenue (2004-2018) 58
5.6 Infectious Immunology, Russian Federation, Distribution Share (2010-2011) 62
5.7 Infectious Immunology, Russian Federation, Company Share (2010-2011) 63
6 Infectious Immunology In India 65
6.1 Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 65
6.2 Infectious Immunology Rapid Tests In India 71
6.2.1 Infectious Immunology Rapid Tests, India, Overall Revenue (2004-2018) 71
6.3 Hepatitis Viruses In India 75
6.3.1 Hepatitis Viruses, India, Overall Revenue (2004-2018) 75
6.4 Retroviruses In India 77
6.4.1 Retroviruses, India, Overall Revenue (2004-2018) 77
6.5 Bacteriology In India 79
6.5.1 Bacteriology, India, Overall Revenue (2004-2018) 79
6.6 Other Virology In India 81
6.6.1 Other Virology, India, Overall Revenue (2004-2018) 81
6.7 Infectious Immunology, India, Distribution Share (2010-2011) 83
6.8 Infectious Immunology, India, Company Share (2010-2011) 84
7 Infectious Immunology In China 86
7.1 Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 86
7.2 Retroviruses In China 92
7.2.1 Retroviruses, China, Overall Revenue (2004-2018) 92
7.3 Hepatitis Viruses In China 94
7.3.1 Hepatitis Viruses, China, Overall Revenue (2004-2018) 94
7.4 Other Virology In China 96
7.4.1 Other Virology, China, Overall Revenue (2004-2018) 96
7.5 Bacteriology In China 98
7.5.1 Bacteriology, China, Overall Revenue (2004-2018) 98
7.6 Infectious Immunology Rapid Tests In China 100
7.6.1 Infectious Immunology Rapid Tests, China, Overall Revenue (2004-2018) 100
7.7 Infectious Immunology, China, Distribution Share (2010-2011) 104
7.8 Infectious Immunology, China, Company Share (2010-2011) 105
8 Infectious Immunology In South Africa 107
8.1 Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107
8.2 Retroviruses In South Africa 113
8.2.1 Retroviruses, South Africa, Overall Revenue (2004-2018) 113
8.3 Hepatitis Viruses In South Africa 115
8.3.1 Hepatitis Viruses, South Africa, Overall Revenue (2004-2018) 115
8.4 Other Virology In South Africa 117
8.4.1 Other Virology, South Africa, Overall Revenue (2004-2018) 117
8.5 Bacteriology In South Africa 119
8.5.1 Bacteriology, South Africa, Overall Revenue (2004-2018) 119
8.6 Infectious Immunology Rapid Tests In South Africa 121
8.6.1 Infectious Immunology Rapid Tests, South Africa, Overall Revenue (2004-2018) 121
8.7 Infectious Immunology, South Africa, Distribution Share (2010-2011) 125
8.8 Infectious Immunology, South Africa, Company Share (2010-2011) 126
9 Overview of Key Companies in BRICS Infectious Immunology Market 128
9.1 Abbott Laboratories 128
9.1.1 Company Overview 128
9.1.2 Share in the BRICS Infectious Immunology Market 129
9.2 F. Hoffmann-La Roche Ltd. 130
9.2.1 Company Overview 130
9.2.2 Share in the BRICS Infectious Immunology Market 131
9.3 Shanghai Kehua Bio-engineering Co., Ltd. 132
9.3.1 Company Overview 132
9.3.2 Share in the BRICS Infectious Immunology Market 132
9.4 Siemens Healthcare 133
9.4.1 Company Overview 133
9.4.2 Share in the BRICS Infectious Immunology Market 134
9.5 bioMerieux S.A. 135
9.5.1 Company Overview 135
9.5.2 Share in the BRICS Infectious Immunology Market 136
9.6 DiaSorin S.p.A 137
9.6.1 Company Overview 137
9.6.2 Share in the BRICS Infectious Immunology Market 138
9.7 Qiagen N.V. 139
9.7.1 Company Overview 139
9.7.2 Share in the BRICS Infectious Immunology Market 140
9.8 Transasia Bio-Medicals Ltd. 141
9.8.1 Company Overview 141
9.8.2 Share in the BRICS Infectious Immunology Market 141
9.9 Alere Inc. 142
9.9.1 Company Overview 142
9.9.2 Share in the BRICS Infectious Immunology Market 143
9.10 Beckman Coulter, Inc. 144
9.10.1 Company Overview 144
9.10.2 Share in the BRICS Infectious Immunology Market 145
9.11 Gen-Probe Incorporated 146
9.11.1 Company Overview 146
9.11.2 Share in the BRICS Infectious Immunology Market 147
9.12 Becton, Dickinson and Company 148
9.12.1 Company Overview 148
9.12.2 Share in the BRICS Infectious Immunology Market 149
9.13 Bio-Rad Laboratories, Inc. 150
9.13.1 Company Overview 150
9.13.2 Share in the BRICS Infectious Immunology Market 151
9.14 PerkinElmer, Inc. 152
9.14.1 Company Overview 152
9.14.2 Share in the BRICS Infectious Immunology Market 153
9.15 Trivitron Healthcare Pvt Ltd. 154
9.15.1 Company Overview 154
9.15.2 Share in the BRICS Infectious Immunology Market 154
9.16 Span Diagnostics Ltd. 155
9.16.1 Company Overview 155
9.16.2 Share in the BRICS Infectious Immunology Market 155
9.17 Thermo Fisher Scientific Inc. 156
9.17.1 Company Overview 156
9.17.2 Share in the BRICS Infectious Immunology Market 157
9.18 Tulip Diagnostics (P) Ltd 158
9.18.1 Company Overview 158
9.18.2 Share in the BRICS Infectious Immunology Market 158
9.19 Cellestis Limited 159
9.19.1 Company Overview 159
9.19.2 Share in the BRICS Infectious Immunology Market 159
9.20 Chembio Diagnostics, Inc. 160
9.20.1 Company Overview 160
9.20.2 Share in the BRICS Infectious Immunology Market 160
9.21 Hologic, Inc. 161
9.21.1 Company Overview 161
9.21.2 Share in the BRICS Infectious Immunology Market 161
10 Appendix 162
10.1 Definitions of Markets Covered in the Report 163
10.1.1 Infectious Immunology 163
10.2 Research Methodology 164
10.3 Secondary Research 164
10.4 Primary Research 165
10.5 Models 165
10.6 Forecasts 166
10.7 Expert Panels 166
10.8 GlobalData Consulting 166
10.9 Currency Conversion 167
10.10 Contact Us 167
10.11 Disclaimer 167



List of Tables

Table 1: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 16
Table 2: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 18
Table 3: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 20
Table 4: Infectious Immunology, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 22
Table 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 24
Table 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 26
Table 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 28
Table 8: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29
Table 9: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30
Table 10: Other Virology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 31
Table 11: Other Virology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 32
Table 12: Retroviruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 33
Table 13: Retroviruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 34
Table 14: Bacteriology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 35
Table 15: Bacteriology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 36
Table 16: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 38
Table 17: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 40
Table 18: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 41
Table 19: Infectious Immunology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 43
Table 20: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 45
Table 21: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 47
Table 22: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 49
Table 23: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 50
Table 24: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 51
Table 25: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 52
Table 26: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 53
Table 27: Other Virology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54
Table 28: Other Virology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55
Table 29: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 56
Table 30: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 57
Table 31: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 59
Table 32: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 61
Table 33: Infectious Immunology, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 62
Table 34: Infectious Immunology, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 64
Table 35: Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 66
Table 36: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68
Table 37: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70
Table 38: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 72
Table 39: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 74
Table 40: Hepatitis Viruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 75
Table 41: Hepatitis Viruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 76
Table 42: Retroviruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 77
Table 43: Retroviruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 78
Table 44: Bacteriology, India, Revenue ($m), USD Constant, Historic, 2004-2011 79
Table 45: Bacteriology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 80
Table 46: Other Virology, India, Revenue ($m), USD Constant, Historic, 2004-2011 81
Table 47: Other Virology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82
Table 48: Infectious Immunology, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 83
Table 49: Infectious Immunology, India, Company Share by Revenue ($m), USD Constant, 2010-2011 85
Table 50: Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 87
Table 51: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 89
Table 52: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 91
Table 53: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92
Table 54: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93
Table 55: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94
Table 56: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95
Table 57: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96
Table 58: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97
Table 59: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98
Table 60: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99
Table 61: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 101
Table 62: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 103
Table 63: Infectious Immunology, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 104
Table 64: Infectious Immunology, China, Company Share by Revenue ($m), USD Constant, 2010-2011 106
Table 65: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 108
Table 66: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 110
Table 67: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 112
Table 68: Retroviruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 113
Table 69: Retroviruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 114
Table 70: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 115
Table 71: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 116
Table 72: Other Virology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 117
Table 73: Other Virology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 118
Table 74: Bacteriology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 119
Table 75: Bacteriology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 120
Table 76: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 122
Table 77: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 124
Table 78: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 125
Table 79: Infectious Immunology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 127
Table 80: Abbott Laboratories, Revenue ($m), BRICS Infectious Immunology Market, 2011 129
Table 81: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 131
Table 82: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 132
Table 83: Siemens Healthcare, Revenue ($m), BRICS Infectious Immunology Market, 2011 134
Table 84: bioMerieux S.A., Revenue ($m), BRICS Infectious Immunology Market, 2011 136
Table 85: DiaSorin S.p.A, Revenue ($m), BRICS Infectious Immunology Market, 2011 138
Table 86: Qiagen N.V., Revenue ($m), BRICS Infectious Immunology Market, 2011 140
Table 87: Transasia Bio-Medicals Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 141
Table 88: Alere Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 143
Table 89: Beckman Coulter, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 145
Table 90: Gen-Probe Incorporated, Revenue ($m), BRICS Infectious Immunology Market, 2011 147
Table 91: Becton, Dickinson and Company, Revenue ($m), BRICS Infectious Immunology Market, 2011 149
Table 92: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 151
Table 93: PerkinElmer, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 153
Table 94: Trivitron Healthcare Pvt Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 154
Table 95: Span Diagnostics Ltd., Revenue ($m), BRICS Infectious Immunology Market, 2011 155
Table 96: Thermo Fisher Scientific Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 157
Table 97: Tulip Diagnostics (P) Ltd, Revenue ($m), BRICS Infectious Immunology Market, 2011 158
Table 98: Cellestis Limited, Revenue ($m), BRICS Infectious Immunology Market, 2011 159
Table 99: Hologic, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 160
Table 100: Hologic, Inc., Revenue ($m), BRICS Infectious Immunology Market, 2011 161



List of Figures

Figure 1: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
Figure 2: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Figure 3: Infectious Immunology, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Figure 4: Infectious Immunology, BRICS, Company share (%), 2011 21
Figure 5: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
Figure 6: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Figure 7: Infectious Immunology, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Figure 8: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29
Figure 9: Hepatitis Viruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30
Figure 10: Other Virology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 31
Figure 11: Other Virology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 32
Figure 12: Retroviruses, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 33
Figure 13: Retroviruses, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 34
Figure 14: Bacteriology, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 35
Figure 15: Bacteriology, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 36
Figure 16: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 37
Figure 17: Infectious Immunology Rapid Tests, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 39
Figure 18: Infectious Immunology, Brazil, Company Share (%), 2011 42
Figure 19: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 44
Figure 20: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 46
Figure 21: Infectious Immunology, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 48
Figure 22: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 50
Figure 23: Hepatitis Viruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 51
Figure 24: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 52
Figure 25: Retroviruses, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 53
Figure 26: Other Virology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54
Figure 27: Other Virology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55
Figure 28: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 56
Figure 29: Bacteriology, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 57
Figure 30: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 58
Figure 31: Infectious Immunology Rapid Tests, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 60
Figure 32: Infectious Immunology, Russian Federation, Company Share (%), 2011 63
Figure 33: Infectious Immunology, India, Overall Revenue ($m), USD Constant, 2004-2018 65
Figure 34: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67
Figure 35: Infectious Immunology, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69
Figure 36: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 71
Figure 37: Infectious Immunology Rapid Tests, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 73
Figure 38: Hepatitis Viruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 75
Figure 39: Hepatitis Viruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 76
Figure 40: Retroviruses, India, Revenue ($m), USD Constant, Historic, 2004-2011 77
Figure 41: Retroviruses, India, Revenue ($m), USD Constant, Forecast, 2011-2018 78
Figure 42: Bacteriology, India, Revenue ($m), USD Constant, Historic, 2004-2011 79
Figure 43: Bacteriology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 80
Figure 44: Other Virology, India, Revenue ($m), USD Constant, Historic, 2004-2011 81
Figure 45: Other Virology, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82
Figure 46: Infectious Immunology, India, Company Share (%), 2011 84
Figure 47: Infectious Immunology, China, Overall Revenue ($m), USD Constant, 2004-2018 86
Figure 48: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 88
Figure 49: Infectious Immunology, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 90
Figure 50: Retroviruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 92
Figure 51: Retroviruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 93
Figure 52: Hepatitis Viruses, China, Revenue ($m), USD Constant, Historic, 2004-2011 94
Figure 53: Hepatitis Viruses, China, Revenue ($m), USD Constant, Forecast, 2011-2018 95
Figure 54: Other Virology, China, Revenue ($m), USD Constant, Historic, 2004-2011 96
Figure 55: Other Virology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 97
Figure 56: Bacteriology, China, Revenue ($m), USD Constant, Historic, 2004-2011 98
Figure 57: Bacteriology, China, Revenue ($m), USD Constant, Forecast, 2011-2018 99
Figure 58: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 100
Figure 59: Infectious Immunology Rapid Tests, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 102
Figure 60: Infectious Immunology, China, Company Share (%), 2011 105
Figure 61: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 107
Figure 62: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 109
Figure 63: Infectious Immunology, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 111
Figure 64: Retroviruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 113
Figure 65: Retroviruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 114
Figure 66: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 115
Figure 67: Hepatitis Viruses, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 116
Figure 68: Other Virology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 117
Figure 69: Other Virology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 118
Figure 70: Bacteriology, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 119
Figure 71: Bacteriology, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 120
Figure 72: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 121
Figure 73: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 123
Figure 74: Infectious Immunology, South Africa, Company Share (%), 2011 126
Figure 75: Abbott Laboratories, Company Share (%), BRICS Infectious Immunology Market, 2011 129
Figure 76: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Infectious Immunology Market, 2011 131
Figure 77: Siemens Healthcare, Company Share (%), BRICS Infectious Immunology Market, 2011 134
Figure 78: bioMerieux S.A., Company Share (%), BRICS Infectious Immunology Market, 2011 136
Figure 79: DiaSorin S.p.A, Company Share (%), BRICS Infectious Immunology Market, 2011 138
Figure 80: Qiagen N.V., Company Share (%), BRICS Infectious Immunology Market, 2011 140
Figure 81: Alere Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 143
Figure 82: Beckman Coulter, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 145
Figure 83: Gen-Probe Incorporated, Company Share (%), BRICS Infectious Immunology Market, 2011 147
Figure 84: Becton, Dickinson and Company, Company Share (%), BRICS Infectious Immunology Market, 2011 149
Figure 85: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 151
Figure 86: PerkinElmer, Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 153
Figure 87: Thermo Fisher Scientific Inc., Company Share (%), BRICS Infectious Immunology Market, 2011 157



Companies Mentioned

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Shanghai Kehua Bio-engineering Co., Ltd.
Siemens Healthcare
bioMerieux S.A.
DiaSorin S.p.A
Qiagen N.V.
Transasia Bio-Medicals Ltd.
Alere Inc.
Beckman Coulter, Inc.
Gen-Probe Incorporated
Becton, Dic